We think Kohl’s is worth $75 a share or more, says Cowen’s Oliver Chen
Oliver Chen, Cowen senior retail analyst, joins ‘Closing Bell’ to discuss Kohl’s price as companies make takeover bids for the company.
02:52
Mon, Jan 24 20223:46 PM EST
Similar Posts
Crowdsourcing your bottom line
Internet lingerie startup “Adore Me” aims to disrupt the U.S. lingerie market. One strategy their using, is to crowdsource the designs they bring to market.
Stocks tick lower after a key inflation indicator came in higher than expected
Jim Cramer and Jeff Marks of the CNBC Investing Club analyze the market tape, dissect the afternoon headlines and get you ready for the final — and most important — hour of trading.
The coronavirus pandemic has caused a surge in demand for contactless payments, accelerating the shift from cash to digital options
The Covid-19 pandemic is expected to cause a drastic decline in cash usage due to the risk of contamination. “Over the past six to eight months, we’ve seen the use of cash decline even further, and that’s a trend I think that we’re going to see continue,” said Jodie Kelley, CEO of Electronic Transactions Association….
Did you know Alcoa helped make all this?
Alcoa is an integral part of consumers’ lives whether they know it or not.
You can’t deal with international trade if not multilaterally, OECD chief says
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Street Signs Angel Gurria, secretary general of the OECD, discusses U.S.-China trade, multilateralism and digital taxes. 06:25 Tue, Jan 21 20208:41 AM EST
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
